Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Barry Uretsky

Concepts (770)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Percutaneous Coronary Intervention
97
2024
307
22.180
Why?
Coronary Occlusion
58
2023
79
12.780
Why?
Coronary Artery Disease
41
2024
294
12.450
Why?
Fractional Flow Reserve, Myocardial
39
2023
127
11.470
Why?
Angioplasty, Balloon, Coronary
55
2020
136
10.960
Why?
Coronary Angiography
114
2023
367
8.700
Why?
Stents
54
2023
351
8.640
Why?
Coronary Vessels
37
2024
166
7.680
Why?
Coronary Stenosis
22
2021
98
6.220
Why?
Myocardial Infarction
52
2024
412
5.260
Why?
Drug-Eluting Stents
22
2023
94
4.900
Why?
Treatment Outcome
128
2024
5422
4.580
Why?
Cardiac Catheterization
33
2023
232
4.000
Why?
Coronary Artery Bypass
19
2022
125
3.050
Why?
Heart Failure
53
2021
565
2.900
Why?
Humans
324
2024
52483
2.870
Why?
Acute Coronary Syndrome
8
2022
80
2.840
Why?
Chronic Disease
55
2023
586
2.410
Why?
Tomography, Optical Coherence
8
2018
109
2.280
Why?
Coronary Disease
26
2015
152
2.210
Why?
Saphenous Vein
14
2021
63
2.210
Why?
Risk Factors
76
2023
3889
2.100
Why?
Graft Occlusion, Vascular
13
2021
75
2.100
Why?
Platelet Aggregation Inhibitors
12
2014
181
2.070
Why?
Coronary Thrombosis
9
2020
23
2.040
Why?
Male
186
2024
26761
1.930
Why?
Myocardial Ischemia
13
2020
121
1.800
Why?
Cardiology
14
2019
97
1.770
Why?
Predictive Value of Tests
27
2023
944
1.760
Why?
Registries
33
2023
581
1.740
Why?
Aged
103
2023
10121
1.710
Why?
Middle Aged
141
2024
13028
1.690
Why?
Coronary Restenosis
8
2021
32
1.670
Why?
Thrombosis
11
2018
253
1.670
Why?
Myocardium
20
2013
453
1.610
Why?
Time Factors
53
2023
2968
1.570
Why?
Heptanoic Acids
15
2008
34
1.520
Why?
Pyrroles
15
2008
71
1.480
Why?
Hydroxymethylglutaryl-CoA Reductase Inhibitors
13
2022
145
1.410
Why?
Risk Assessment
30
2023
1327
1.390
Why?
Heart Injuries
3
2019
16
1.350
Why?
Female
140
2024
28171
1.300
Why?
Cardiac Tamponade
4
2024
28
1.260
Why?
Cardiotonic Agents
23
2019
82
1.260
Why?
Ventricular Function, Left
16
2023
172
1.260
Why?
Myocardial Reperfusion Injury
10
2011
48
1.210
Why?
Hemodynamics
38
2018
263
1.130
Why?
Postoperative Complications
17
2019
1068
1.130
Why?
Collateral Circulation
10
2020
38
1.130
Why?
Vasodilator Agents
8
2016
96
1.090
Why?
Coronary Circulation
11
2024
57
1.040
Why?
Societies, Medical
10
2019
200
1.030
Why?
Heart-Assist Devices
4
2020
163
1.020
Why?
Heart Transplantation
28
2009
367
0.980
Why?
Contrast Media
9
2018
193
0.960
Why?
Ventricular Dysfunction, Left
8
2018
108
0.950
Why?
Prosthesis Design
11
2021
256
0.950
Why?
Cardiac Catheters
4
2020
11
0.950
Why?
Thrombolytic Therapy
2
2020
110
0.940
Why?
Death, Sudden, Cardiac
6
2008
59
0.900
Why?
Pericarditis
2
2022
20
0.900
Why?
Balloon Occlusion
1
2024
17
0.870
Why?
Adenosine
7
2018
71
0.870
Why?
Algorithms
6
2021
672
0.850
Why?
Pericardial Effusion
1
2024
39
0.850
Why?
Hemorrhage
4
2019
209
0.840
Why?
Digitalis
2
2021
5
0.840
Why?
Cardiovascular Agents
5
2009
59
0.820
Why?
Aneurysm, False
5
2020
42
0.810
Why?
Occupational Health
1
2023
66
0.810
Why?
Pericarditis, Constrictive
1
2022
2
0.800
Why?
Aorta
4
2019
165
0.770
Why?
Hypotension, Controlled
1
2021
3
0.750
Why?
Radiography, Interventional
7
2018
57
0.750
Why?
Retrospective Studies
31
2020
6607
0.750
Why?
Anemia
1
2022
74
0.730
Why?
Angina, Unstable
8
2016
24
0.720
Why?
Thrombocytopenia
1
2022
89
0.720
Why?
Mammary Arteries
3
2017
8
0.720
Why?
Absorbable Implants
2
2022
13
0.710
Why?
Follow-Up Studies
27
2019
2279
0.700
Why?
Prognosis
19
2023
2099
0.690
Why?
Inferior Wall Myocardial Infarction
1
2020
1
0.690
Why?
Thiazolidinediones
6
2008
83
0.680
Why?
Time-to-Treatment
2
2020
78
0.670
Why?
Shock, Cardiogenic
1
2020
30
0.660
Why?
Digoxin
11
2021
29
0.650
Why?
Cardiovascular Diseases
11
2015
490
0.650
Why?
Diabetic Angiopathies
2
2013
23
0.640
Why?
Stroke Volume
18
2023
155
0.640
Why?
Enbucrilate
1
2019
6
0.640
Why?
Tissue Adhesives
1
2019
13
0.640
Why?
Prospective Studies
28
2023
2481
0.640
Why?
Heart Ventricles
8
2012
267
0.640
Why?
Arterial Pressure
1
2019
45
0.640
Why?
Hyperemia
3
2016
17
0.630
Why?
Pericardium
4
2022
29
0.630
Why?
Practice Guidelines as Topic
3
2020
488
0.630
Why?
Operative Time
3
2019
77
0.620
Why?
Guideline Adherence
1
2020
138
0.620
Why?
Adrenergic beta-Antagonists
5
2008
110
0.610
Why?
Aspirin
5
2022
115
0.590
Why?
Troponin T
3
2011
12
0.590
Why?
Hematoma
2
2013
65
0.590
Why?
Electrocardiography
15
2022
268
0.580
Why?
Severity of Illness Index
19
2019
1026
0.580
Why?
Heart Septum
3
2010
23
0.570
Why?
Hydrostatic Pressure
1
2017
7
0.570
Why?
Angioplasty, Balloon
4
2022
68
0.550
Why?
Perioperative Care
5
2015
43
0.550
Why?
Creatine Kinase, MB Form
3
2013
6
0.550
Why?
Angiotensin-Converting Enzyme Inhibitors
10
2011
78
0.550
Why?
Surgical Procedures, Operative
4
2015
64
0.530
Why?
Foramen Ovale, Patent
2
2014
31
0.530
Why?
Defibrillators, Implantable
5
2007
69
0.530
Why?
Purinergic P2Y Receptor Antagonists
2
2014
29
0.520
Why?
Propranolol
3
2008
78
0.510
Why?
United States
27
2022
5192
0.500
Why?
Heart
10
2006
345
0.500
Why?
Kidney Failure, Chronic
4
2004
210
0.500
Why?
Randomized Controlled Trials as Topic
12
2021
595
0.500
Why?
Veterans
1
2022
583
0.490
Why?
Alloys
2
2020
9
0.490
Why?
Tissue Donors
2
2013
126
0.490
Why?
Incidence
16
2018
1062
0.480
Why?
Heart Rupture, Post-Infarction
3
2005
5
0.480
Why?
Aortic Valve
3
2022
123
0.470
Why?
Physician-Patient Relations
2
2015
143
0.470
Why?
Fibrinolytic Agents
3
2014
128
0.470
Why?
Vascular System Injuries
1
2015
38
0.460
Why?
Wounds, Penetrating
1
2015
39
0.460
Why?
Tomography, X-Ray Computed
5
2013
1165
0.460
Why?
Ultrasonography, Interventional
7
2013
140
0.450
Why?
Purines
2
2014
34
0.450
Why?
Adenosine A2 Receptor Agonists
1
2014
5
0.440
Why?
Platelet Glycoprotein GPIIb-IIIa Complex
3
2009
33
0.440
Why?
Lisinopril
7
2003
13
0.440
Why?
Anterior Wall Myocardial Infarction
2
2012
7
0.430
Why?
Computer-Assisted Instruction
1
2014
30
0.430
Why?
Metals
2
2011
36
0.430
Why?
Clinical Trials as Topic
9
2012
467
0.430
Why?
Cyclooxygenase 2
8
2008
48
0.430
Why?
Piperazines
2
2012
118
0.420
Why?
Blood Vessel Prosthesis Implantation
4
2009
121
0.420
Why?
Anticholesteremic Agents
3
2008
31
0.420
Why?
Pyrazoles
2
2014
114
0.420
Why?
Coronary Vessel Anomalies
3
2017
36
0.420
Why?
Mentors
1
2014
57
0.420
Why?
Arteries
1
2013
92
0.420
Why?
Atrial Function, Left
1
2013
5
0.410
Why?
Endarterectomy, Carotid
2
2011
62
0.410
Why?
Lipoxins
3
2008
3
0.410
Why?
Imidazoles
9
1990
124
0.410
Why?
Drug Administration Schedule
7
2014
374
0.400
Why?
Coronary Aneurysm
2
2007
19
0.400
Why?
Cardiac Surgical Procedures
3
2014
321
0.400
Why?
Pressure
4
2017
104
0.400
Why?
Drug Eruptions
1
2012
14
0.390
Why?
Rats, Sprague-Dawley
14
2008
1563
0.390
Why?
Physicians
2
2015
241
0.390
Why?
Rats
19
2011
3220
0.390
Why?
Thiophenes
1
2012
38
0.390
Why?
Stroke
3
2013
512
0.380
Why?
Quality Assurance, Health Care
4
2012
149
0.370
Why?
Embolism
2
2013
20
0.370
Why?
Cyclooxygenase Inhibitors
5
2007
39
0.370
Why?
Double-Blind Method
14
2020
713
0.370
Why?
Internet
1
2014
263
0.370
Why?
Diverticulum
1
2011
21
0.370
Why?
Troponin I
1
2011
18
0.360
Why?
Transurethral Resection of Prostate
1
2011
10
0.360
Why?
Intraoperative Complications
4
2020
112
0.360
Why?
Carotid Arteries
1
2011
77
0.360
Why?
Receptors, Adrenergic, beta-2
2
2009
16
0.350
Why?
Myocytes, Cardiac
5
2011
129
0.350
Why?
Embolic Protection Devices
1
2010
6
0.350
Why?
Paclitaxel
1
2011
89
0.350
Why?
Receptors, Opioid, delta
2
2009
25
0.350
Why?
Clinical Competence
4
2013
406
0.350
Why?
Pericardiectomy
2
2024
6
0.340
Why?
Mitral Valve
1
2010
52
0.340
Why?
Endocarditis
1
2010
31
0.330
Why?
Kaplan-Meier Estimate
6
2017
483
0.330
Why?
Calcinosis
4
2023
51
0.320
Why?
Anticoagulants
6
2024
270
0.320
Why?
Suction
2
2008
24
0.320
Why?
Sirolimus
2
2009
65
0.310
Why?
Echocardiography, Transesophageal
2
2006
60
0.310
Why?
Adult
44
2019
14161
0.300
Why?
Hypoglycemic Agents
3
2006
211
0.300
Why?
Carotid Artery, Common
2
2006
44
0.300
Why?
Heart Valve Prosthesis
3
2022
86
0.300
Why?
Myocardial Bridging
1
2008
2
0.300
Why?
Tissue Plasminogen Activator
1
2009
109
0.300
Why?
Heart Failure, Systolic
1
2008
7
0.300
Why?
Aortic Valve Stenosis
3
2022
76
0.290
Why?
Peptides
2
2008
223
0.290
Why?
Azetidines
1
2008
6
0.290
Why?
Creatinine
3
2004
150
0.290
Why?
Patient Selection
7
2012
259
0.290
Why?
Consensus
2
2007
181
0.290
Why?
Exercise Test
10
2002
141
0.280
Why?
Cardiac Output, Low
4
2006
12
0.280
Why?
Heart Septal Defects, Atrial
2
2013
45
0.280
Why?
Telemedicine
1
2014
494
0.280
Why?
Animals
28
2022
13505
0.270
Why?
Vascular Patency
5
2020
82
0.270
Why?
Mitral Valve Insufficiency
3
2007
52
0.270
Why?
Laboratories, Hospital
1
2006
6
0.270
Why?
Aortic Valve Insufficiency
2
2016
26
0.270
Why?
Survival Analysis
11
2010
673
0.260
Why?
Terminology as Topic
3
2013
70
0.260
Why?
Echocardiography, Three-Dimensional
1
2006
15
0.260
Why?
Chi-Square Distribution
3
2017
288
0.260
Why?
Drug Therapy, Combination
9
2008
395
0.260
Why?
Pacemaker, Artificial
1
2007
44
0.250
Why?
Proportional Hazards Models
8
2017
443
0.250
Why?
Bacteremia
1
2007
92
0.250
Why?
Gadolinium DTPA
1
2005
25
0.240
Why?
Inpatients
2
2018
205
0.240
Why?
Chest Pain
3
2006
57
0.240
Why?
Nitric Oxide Synthase Type III
6
2008
78
0.240
Why?
Carotid Artery Diseases
1
2005
31
0.240
Why?
Lipopolysaccharides
1
2006
206
0.240
Why?
Neovascularization, Physiologic
2
2005
72
0.240
Why?
Calcium
1
2007
376
0.240
Why?
Angina, Stable
2
2016
7
0.240
Why?
Prostaglandins
1
2005
19
0.240
Why?
Europe
8
2019
87
0.240
Why?
Program Evaluation
1
2006
353
0.230
Why?
Pain Management
3
2015
178
0.230
Why?
Renal Insufficiency
1
2005
113
0.230
Why?
Atrial Fibrillation
4
2021
200
0.230
Why?
Chemokine CCL2
1
2004
69
0.230
Why?
Dose-Response Relationship, Drug
12
2017
1378
0.230
Why?
Metabolic Clearance Rate
1
2004
69
0.230
Why?
Plasminogen Activator Inhibitor 1
1
2004
7
0.230
Why?
Equipment Design
4
2020
293
0.220
Why?
History, 21st Century
2
2019
59
0.220
Why?
Angiography
7
2012
114
0.220
Why?
Pericardiocentesis
1
2024
15
0.220
Why?
Femoral Artery
4
2019
103
0.220
Why?
Monocytes
1
2004
130
0.220
Why?
History, 20th Century
2
2019
96
0.220
Why?
Artifacts
1
2004
55
0.220
Why?
Reoperation
5
2013
465
0.220
Why?
Secondary Prevention
2
2015
84
0.220
Why?
Arginine Vasopressin
5
2005
11
0.220
Why?
Reproducibility of Results
6
2016
1229
0.220
Why?
Recurrence
7
2016
672
0.210
Why?
Staphylococcal Infections
1
2007
285
0.210
Why?
Cardiomyopathy, Hypertrophic
1
2004
33
0.210
Why?
Angina Pectoris
4
2020
19
0.210
Why?
Nitric Oxide Synthase Type II
4
2008
62
0.210
Why?
Disease Models, Animal
10
2011
1478
0.210
Why?
Risk
7
2011
316
0.210
Why?
Catheterization
4
2019
96
0.200
Why?
Aged, 80 and over
10
2017
3392
0.200
Why?
Materials Testing
2
2020
58
0.200
Why?
American Heart Association
4
2015
32
0.200
Why?
Hospital Mortality
5
2019
435
0.200
Why?
Anti-Arrhythmia Agents
4
2004
81
0.190
Why?
Cyclosporins
5
1989
8
0.190
Why?
Vasodilation
2
2021
99
0.190
Why?
Body Composition
1
2004
338
0.190
Why?
Constriction, Pathologic
3
2017
91
0.190
Why?
Odds Ratio
4
2016
558
0.190
Why?
Exercise Tolerance
5
1997
46
0.190
Why?
Propanolamines
3
2011
14
0.190
Why?
Retreatment
2
2012
58
0.180
Why?
Diet, Sodium-Restricted
1
2000
5
0.170
Why?
Enalapril
3
1989
15
0.170
Why?
Up-Regulation
4
2011
454
0.170
Why?
Heart Valve Prosthesis Implantation
2
2016
96
0.170
Why?
United States Department of Veterans Affairs
1
2022
293
0.170
Why?
Ischemia
1
2021
150
0.170
Why?
Logistic Models
5
2018
925
0.170
Why?
Hospitalization
5
2011
736
0.170
Why?
Angioplasty
1
2020
20
0.170
Why?
Calcitonin Gene-Related Peptide
2
2009
24
0.160
Why?
Administration, Oral
8
2015
451
0.160
Why?
6-Ketoprostaglandin F1 alpha
3
2008
4
0.160
Why?
Life Style
1
2000
145
0.160
Why?
Dobutamine
5
1999
20
0.160
Why?
Plaque, Atherosclerotic
1
2019
44
0.160
Why?
Heart Rate
7
1993
318
0.160
Why?
Specialization
1
2019
49
0.160
Why?
Atherectomy
1
2019
13
0.160
Why?
Cost-Benefit Analysis
2
2014
267
0.150
Why?
Atrial Natriuretic Factor
4
1996
25
0.150
Why?
Russia
4
2019
10
0.150
Why?
Quality Improvement
2
2011
226
0.150
Why?
Radial Artery
1
2019
34
0.150
Why?
Prevalence
5
2018
1006
0.150
Why?
Peripheral Arterial Disease
1
2019
75
0.150
Why?
Proto-Oncogene Proteins c-akt
3
2009
169
0.150
Why?
Feasibility Studies
2
2020
406
0.150
Why?
Catheterization, Peripheral
1
2019
49
0.150
Why?
Patient Care Planning
1
2019
68
0.150
Why?
Tachycardia, Ventricular
2
2004
46
0.150
Why?
Cardiomyopathies
8
2003
121
0.140
Why?
Patient Care
1
1998
57
0.140
Why?
Emergency Medical Services
1
2019
114
0.140
Why?
Patient Safety
1
2018
104
0.140
Why?
Multivariate Analysis
6
2016
591
0.140
Why?
Fistula
2
1996
27
0.140
Why?
Blood Pressure
12
1997
537
0.140
Why?
Diabetes Mellitus, Type 2
1
2004
560
0.140
Why?
Medicare
2
2011
274
0.140
Why?
Education, Medical
1
2019
111
0.140
Why?
Waiting Lists
3
2007
55
0.140
Why?
Adventitia
1
2017
4
0.140
Why?
Cardiac Pacing, Artificial
3
2008
34
0.140
Why?
Education, Medical, Graduate
3
2013
219
0.140
Why?
Curriculum
3
2013
398
0.140
Why?
Quality of Life
5
2008
879
0.130
Why?
Enoximone
9
1990
10
0.130
Why?
Advisory Committees
2
2014
71
0.130
Why?
Myocardial Revascularization
3
2012
21
0.130
Why?
Epoprostenol
4
1997
16
0.130
Why?
Substance Withdrawal Syndrome
2
1997
168
0.130
Why?
Nitric Oxide Synthase
2
2008
62
0.130
Why?
Phosphorylation
6
2008
528
0.130
Why?
Hypertension, Pulmonary
7
1997
130
0.130
Why?
Simvastatin
2
2008
29
0.130
Why?
Treatment Failure
4
2018
122
0.130
Why?
Propensity Score
1
2017
154
0.130
Why?
Hypertension
6
2011
565
0.120
Why?
Health Personnel
3
2007
256
0.120
Why?
Benzazepines
2
2006
20
0.120
Why?
Phosphodiesterase Inhibitors
4
2007
24
0.120
Why?
Renal Insufficiency, Chronic
1
2018
187
0.120
Why?
Muscle Contraction
1
1996
117
0.120
Why?
Postpericardiotomy Syndrome
1
2015
4
0.120
Why?
Diagnostic Techniques, Cardiovascular
2
2012
4
0.120
Why?
Magnetic Resonance Imaging
1
2022
1546
0.120
Why?
Angioscopy
1
1994
3
0.120
Why?
Age Factors
5
2021
1132
0.120
Why?
Colchicine
1
2015
24
0.120
Why?
Cardiomyopathy, Dilated
3
1996
40
0.120
Why?
Renin
4
1996
18
0.120
Why?
Smad3 Protein
1
2014
9
0.120
Why?
Systole
4
2010
72
0.120
Why?
Norepinephrine
5
1996
112
0.120
Why?
Cholesterol, Dietary
1
2014
19
0.110
Why?
Th2 Cells
1
2014
23
0.110
Why?
Tunica Intima
1
1994
55
0.110
Why?
Cyclic AMP-Dependent Protein Kinases
3
2011
50
0.110
Why?
Patient Care Management
1
2014
18
0.110
Why?
Venous Thrombosis
1
2015
90
0.110
Why?
Area Under Curve
3
2022
180
0.110
Why?
Myocardial Contraction
4
2009
112
0.110
Why?
Receptors, LDL
1
2014
71
0.110
Why?
Acute Disease
5
2019
373
0.110
Why?
Disease Progression
5
2008
871
0.110
Why?
Cardiovascular System
1
2014
53
0.110
Why?
Punctures
3
2019
52
0.110
Why?
Atherosclerosis
2
2014
219
0.110
Why?
Diuretics
4
1998
31
0.110
Why?
Thromboembolism
1
2014
52
0.110
Why?
Cohort Studies
6
2022
1542
0.110
Why?
Dependovirus
1
2014
103
0.110
Why?
Transfection
1
2014
357
0.110
Why?
Cardiac Output
10
1997
42
0.110
Why?
Remote Consultation
1
2014
29
0.110
Why?
Survival Rate
6
2018
945
0.110
Why?
Drug Costs
1
2014
39
0.110
Why?
Quality Indicators, Health Care
2
2011
90
0.110
Why?
Arrhythmias, Cardiac
2
2012
96
0.110
Why?
Septal Occluder Device
1
2013
36
0.100
Why?
Case-Control Studies
3
2013
1201
0.100
Why?
Echocardiography, Doppler, Color
1
2013
21
0.100
Why?
Pulmonary Edema
1
2013
15
0.100
Why?
Echocardiography, Doppler
2
2016
57
0.100
Why?
Hypertrophy, Left Ventricular
3
2009
42
0.100
Why?
Pulmonary Wedge Pressure
7
1997
25
0.100
Why?
General Surgery
1
2014
105
0.100
Why?
Heparin
2
2024
88
0.100
Why?
Signal Transduction
3
2009
1671
0.100
Why?
Evidence-Based Medicine
2
2011
261
0.100
Why?
Cause of Death
7
2007
160
0.100
Why?
Pleural Effusion
1
2013
38
0.100
Why?
Ultrasonography
3
2010
430
0.100
Why?
Kidney Diseases
2
2007
220
0.100
Why?
Echocardiography
7
2005
415
0.100
Why?
Graft Rejection
8
2009
177
0.100
Why?
Image Processing, Computer-Assisted
1
2014
253
0.100
Why?
Infusions, Intravenous
7
2011
220
0.100
Why?
Embolism, Cholesterol
1
2011
2
0.100
Why?
Creatine Kinase
2
2003
29
0.100
Why?
Sex Factors
5
2022
727
0.090
Why?
Carbazoles
2
2005
18
0.090
Why?
Cardiovascular Surgical Procedures
2
2012
12
0.090
Why?
Equipment Failure
3
2008
64
0.090
Why?
Random Allocation
4
2005
285
0.090
Why?
Milrinone
1
2011
9
0.090
Why?
Exercise
1
1996
547
0.090
Why?
Isoenzymes
2
2003
166
0.090
Why?
Insurance Claim Review
1
2011
40
0.090
Why?
Death
2
2022
23
0.090
Why?
Diabetes Complications
3
2011
122
0.090
Why?
Enkephalin, D-Penicillamine (2,5)-
2
2009
3
0.090
Why?
Unnecessary Procedures
1
2011
20
0.090
Why?
Prednisone
3
1989
102
0.090
Why?
Oxygen Consumption
5
1996
198
0.090
Why?
Body Weight
3
2007
523
0.090
Why?
Preoperative Care
2
2007
173
0.090
Why?
Thrombectomy
1
2011
72
0.080
Why?
Necrosis
1
2010
176
0.080
Why?
Injections, Intra-Arterial
2
2015
13
0.080
Why?
Cyclooxygenase 2 Inhibitors
2
2007
21
0.080
Why?
Texas
4
2006
143
0.080
Why?
Surgical Instruments
1
2010
28
0.080
Why?
Disease Management
3
2014
188
0.080
Why?
Cells, Cultured
4
2009
1567
0.080
Why?
Reperfusion Injury
2
2007
70
0.080
Why?
Magnetic Resonance Imaging, Cine
1
2010
62
0.080
Why?
Diatrizoate
1
1989
2
0.080
Why?
Iopamidol
1
1989
2
0.080
Why?
Receptors, Calcitonin Gene-Related Peptide
1
2009
4
0.080
Why?
Ethanolamines
2
1986
13
0.080
Why?
ROC Curve
2
2022
253
0.080
Why?
Endothelium, Vascular
2
2007
246
0.080
Why?
Hyperlipidemias
2
2011
52
0.080
Why?
Drug Administration Routes
1
2008
10
0.080
Why?
Leukotriene B4
1
2008
1
0.080
Why?
Arachidonate 5-Lipoxygenase
1
2008
3
0.080
Why?
Fatal Outcome
2
2007
197
0.080
Why?
Hemostasis, Surgical
1
2008
12
0.080
Why?
Phospholipases A
2
2006
14
0.080
Why?
Phospholipases A2
2
2006
15
0.080
Why?
Patient Transfer
1
2009
99
0.070
Why?
Comorbidity
1
2010
625
0.070
Why?
Meta-Analysis as Topic
1
2008
40
0.070
Why?
Analysis of Variance
2
2008
554
0.070
Why?
Drainage
1
2008
87
0.070
Why?
Sulfonamides
2
2008
133
0.070
Why?
Kidney
3
2005
707
0.070
Why?
Heart Diseases
3
2006
216
0.070
Why?
Myocardial Reperfusion
1
2007
9
0.070
Why?
Mitogen-Activated Protein Kinase 3
1
2007
49
0.070
Why?
Tetrazoles
1
2007
41
0.070
Why?
Combined Modality Therapy
1
2009
639
0.070
Why?
Dipyridamole
1
2007
8
0.070
Why?
Prosthesis Failure
2
2012
111
0.070
Why?
Microinjections
2
2018
35
0.070
Why?
Prostaglandin D2
1
2007
22
0.070
Why?
Cyclooxygenase 1
1
2007
7
0.070
Why?
Drug Interactions
2
2007
206
0.070
Why?
Calcium Signaling
1
2007
51
0.070
Why?
Nitroso Compounds
1
2006
3
0.070
Why?
Patient Admission
1
2007
78
0.070
Why?
Thoracic Surgery
1
2007
22
0.070
Why?
Enzyme Induction
1
2006
77
0.070
Why?
Mass Screening
2
2004
357
0.070
Why?
Anemia, Macrocytic
1
1986
2
0.070
Why?
Deferoxamine
1
1986
9
0.070
Why?
Anemia, Megaloblastic
1
1986
3
0.070
Why?
PPAR gamma
1
2007
72
0.070
Why?
Biotin
1
2006
46
0.070
Why?
Ubiquinone
1
2006
14
0.060
Why?
NF-kappa B
1
2008
322
0.060
Why?
Hemofiltration
1
2006
7
0.060
Why?
Magnesium
1
2006
31
0.060
Why?
Electric Countershock
1
2006
30
0.060
Why?
Multicenter Studies as Topic
4
2005
105
0.060
Why?
Forecasting
1
2007
154
0.060
Why?
Diagnosis, Differential
2
2012
1046
0.060
Why?
Intracranial Embolism
1
2006
29
0.060
Why?
Patient Education as Topic
2
2000
321
0.060
Why?
Radiology
1
2008
134
0.060
Why?
Heart Atria
1
2006
63
0.060
Why?
Antihypertensive Agents
2
1997
132
0.060
Why?
Ischemic Preconditioning
1
2005
6
0.060
Why?
Aortic Rupture
1
2006
17
0.060
Why?
Triiodobenzoic Acids
1
2005
9
0.060
Why?
Partnership Practice
1
2005
1
0.060
Why?
Organizational Affiliation
1
2005
2
0.060
Why?
Myocardial Stunning
1
2005
2
0.060
Why?
Health Planning
1
2005
13
0.060
Why?
Metoprolol
1
2005
13
0.060
Why?
Foreign Bodies
1
2006
66
0.060
Why?
Pyrrolidines
1
2006
69
0.060
Why?
Device Removal
1
2006
82
0.060
Why?
Anti-Inflammatory Agents, Non-Steroidal
1
2006
122
0.060
Why?
Gastrointestinal Hemorrhage
1
2006
89
0.060
Why?
Iron
1
1986
127
0.060
Why?
Aortic Coarctation
1
2006
31
0.060
Why?
Sensitivity and Specificity
3
2006
891
0.060
Why?
Water-Electrolyte Balance
1
1985
20
0.060
Why?
Accidents, Traffic
1
2006
90
0.060
Why?
Isoxazoles
1
2005
15
0.060
Why?
Intramolecular Oxidoreductases
1
2005
11
0.060
Why?
Prostaglandin-Endoperoxide Synthases
1
2005
25
0.060
Why?
Education, Medical, Continuing
1
2005
72
0.060
Why?
Tetralogy of Fallot
1
2006
86
0.060
Why?
Ephedrine
1
2004
21
0.060
Why?
Regional Blood Flow
1
2004
109
0.060
Why?
Leadership
1
2005
103
0.060
Why?
Hyperhomocysteinemia
1
2004
29
0.060
Why?
Body Surface Area
1
2004
27
0.060
Why?
Membrane Proteins
1
2007
335
0.060
Why?
Polyethylene Terephthalates
1
2004
10
0.060
Why?
Brachiocephalic Trunk
1
2004
6
0.060
Why?
Ventricular Remodeling
1
2004
64
0.060
Why?
Antioxidants
1
2006
256
0.060
Why?
Pregnancy Complications, Cardiovascular
1
2004
37
0.060
Why?
Vascular Endothelial Growth Factor A
1
2005
182
0.060
Why?
Abnormalities, Multiple
1
2006
166
0.060
Why?
Injections, Intravenous
4
2004
138
0.060
Why?
Arteriosclerosis
1
2004
53
0.060
Why?
Swine Diseases
1
2004
7
0.060
Why?
Myocarditis
1
1984
49
0.050
Why?
ATP-Binding Cassette Transporters
1
2004
34
0.050
Why?
Potassium Channels
1
2004
32
0.050
Why?
Enoxaparin
1
2024
31
0.050
Why?
Inflammation
2
2007
641
0.050
Why?
Edema
1
2004
66
0.050
Why?
Cytochrome P-450 Enzyme System
1
2005
191
0.050
Why?
Vasoconstrictor Agents
1
2004
82
0.050
Why?
Immunohistochemistry
2
2005
979
0.050
Why?
Radiography
3
2006
470
0.050
Why?
Glomerular Filtration Rate
2
2018
124
0.050
Why?
Staphylococcus aureus
1
2007
338
0.050
Why?
Sample Size
1
2003
44
0.050
Why?
Heart Aneurysm
1
1983
13
0.050
Why?
Retroperitoneal Space
1
2002
26
0.050
Why?
C-Reactive Protein
1
2003
155
0.050
Why?
Methoxamine
2
1993
4
0.050
Why?
Internship and Residency
1
2008
448
0.050
Why?
Mitral Valve Prolapse
1
1982
3
0.050
Why?
Drug Synergism
3
2007
150
0.050
Why?
Morphine Derivatives
1
2022
27
0.050
Why?
Renal Dialysis
1
2003
179
0.050
Why?
Anesthesia
1
2002
71
0.050
Why?
Pain Clinics
1
2001
3
0.050
Why?
Hospital Units
1
2001
11
0.050
Why?
Hospitals
1
2022
182
0.050
Why?
Dogs
3
1993
180
0.050
Why?
Benchmarking
2
2011
64
0.040
Why?
Nitroglycerin
3
2004
8
0.040
Why?
Comprehensive Health Care
1
2000
9
0.040
Why?
Fluoroscopy
2
1993
50
0.040
Why?
Heart Arrest
1
2002
158
0.040
Why?
Cardiology Service, Hospital
1
2000
15
0.040
Why?
Autopsy
1
2000
48
0.040
Why?
Tissue Scaffolds
1
2020
40
0.040
Why?
Vitamins
1
2000
64
0.040
Why?
Biocompatible Materials
1
2020
67
0.040
Why?
Arkansas
2
2016
2028
0.040
Why?
Amyloidosis
2
1991
85
0.040
Why?
Public Policy
2
2012
38
0.040
Why?
Diastole
2
1993
70
0.040
Why?
Anti-Inflammatory Agents
2
2015
166
0.040
Why?
Peripheral Vascular Diseases
1
2000
23
0.040
Why?
Renal Artery Obstruction
1
2000
21
0.040
Why?
Oxidative Stress
1
2004
807
0.040
Why?
Disease-Free Survival
1
2000
460
0.040
Why?
Hospitals, Public
1
1999
7
0.040
Why?
Placebos
2
1990
85
0.040
Why?
Carotid Stenosis
1
2000
66
0.040
Why?
Syndrome
3
2006
247
0.040
Why?
Morbidity
1
1999
145
0.040
Why?
Risk Adjustment
1
2019
16
0.040
Why?
Mice, Knockout
2
2014
879
0.040
Why?
Injections, Intralesional
1
2018
31
0.040
Why?
Quality of Health Care
1
2000
187
0.040
Why?
Adolescent
7
1996
6739
0.040
Why?
Internationality
1
2018
43
0.040
Why?
Radiation Dosage
1
2019
163
0.040
Why?
Patient Care Team
1
2000
272
0.040
Why?
Drug Evaluation
2
1995
26
0.040
Why?
Ventricular Pressure
1
1997
16
0.040
Why?
Immunoblotting
2
2008
116
0.040
Why?
Administration, Intravenous
1
2018
73
0.040
Why?
Health Services Needs and Demand
1
1999
159
0.040
Why?
Internal Mammary-Coronary Artery Anastomosis
1
1997
5
0.030
Why?
Respiration
2
1996
101
0.030
Why?
Radiation Monitoring
1
2017
7
0.030
Why?
Calcium Channel Blockers
1
1997
60
0.030
Why?
International Cooperation
2
2007
49
0.030
Why?
Cardiomegaly
2
1988
38
0.030
Why?
Biopsy
5
1994
605
0.030
Why?
Enzyme-Linked Immunosorbent Assay
2
2008
235
0.030
Why?
Patient Compliance
1
1998
230
0.030
Why?
Ventricular Function, Right
1
1997
42
0.030
Why?
Hormones
2
1987
59
0.030
Why?
Isotonic Contraction
1
1996
1
0.030
Why?
Isometric Contraction
1
1996
21
0.030
Why?
Vascular Resistance
3
1997
51
0.030
Why?
Forearm
1
1996
32
0.030
Why?
Socioeconomic Factors
1
1998
610
0.030
Why?
Italy
1
2015
26
0.030
Why?
Data Collection
3
2011
290
0.030
Why?
Mice
3
2014
5949
0.030
Why?
Carbon Dioxide
1
1996
97
0.030
Why?
Delivery of Health Care
1
1998
323
0.030
Why?
Blood Flow Velocity
1
2015
95
0.030
Why?
Phlebography
1
2015
55
0.030
Why?
Neurotransmitter Agents
1
1995
34
0.030
Why?
Radionuclide Angiography
1
1994
1
0.030
Why?
Tubulin Modulators
1
2015
27
0.030
Why?
Atherectomy, Coronary
1
1994
5
0.030
Why?
Cross-Sectional Studies
1
2020
1678
0.030
Why?
Time
1
2014
28
0.030
Why?
Journal Impact Factor
1
2014
8
0.030
Why?
Models, Cardiovascular
2
2004
20
0.030
Why?
Kinetics
2
1986
626
0.030
Why?
Genetic Vectors
1
2014
128
0.030
Why?
Nervous System Diseases
1
1995
95
0.030
Why?
Fibrosis
1
2014
196
0.030
Why?
Pulmonary Circulation
1
1993
29
0.030
Why?
Monitoring, Physiologic
1
2014
122
0.030
Why?
Learning Curve
1
2013
19
0.030
Why?
Drug Monitoring
1
1993
83
0.030
Why?
Ischemic Attack, Transient
1
2013
57
0.030
Why?
Ultrasonics
1
1993
29
0.030
Why?
Apoptosis
2
2011
1119
0.030
Why?
Jugular Veins
1
1993
34
0.030
Why?
Cardiac Imaging Techniques
1
2012
9
0.020
Why?
Gene Expression Regulation
2
2008
990
0.020
Why?
Alprostadil
1
1992
10
0.020
Why?
Mice, Inbred C57BL
2
2008
1884
0.020
Why?
Intra-Aortic Balloon Pumping
1
1992
6
0.020
Why?
Tissue Survival
1
2012
10
0.020
Why?
Myocardial Perfusion Imaging
1
2012
17
0.020
Why?
Smoking
2
2011
520
0.020
Why?
Obesity
1
2000
1162
0.020
Why?
Endocardium
2
1989
7
0.020
Why?
Tomography, Emission-Computed, Single-Photon
1
2012
52
0.020
Why?
Phosphodiesterase 3 Inhibitors
1
2011
1
0.020
Why?
Health Status
1
1993
294
0.020
Why?
Adrenergic beta-1 Receptor Antagonists
1
2011
6
0.020
Why?
In Situ Nick-End Labeling
1
2011
53
0.020
Why?
Health Policy
1
2012
158
0.020
Why?
Adrenergic beta-Agonists
1
1991
42
0.020
Why?
Goals
1
1991
43
0.020
Why?
Recovery of Function
1
2012
199
0.020
Why?
Diagnostic Imaging
1
2012
181
0.020
Why?
Mannitol
1
1990
15
0.020
Why?
Critical Care
1
2012
222
0.020
Why?
Body Water
1
1990
27
0.020
Why?
Dopamine
1
1991
173
0.020
Why?
Vasoconstriction
1
1990
55
0.020
Why?
Sodium
1
1990
95
0.020
Why?
Blood Volume
1
1990
66
0.020
Why?
Program Development
1
2011
165
0.020
Why?
Graft Survival
1
1991
160
0.020
Why?
Adrenergic beta-2 Receptor Antagonists
1
2009
1
0.020
Why?
Adrenergic beta-2 Receptor Agonists
1
2009
5
0.020
Why?
Transplantation, Homologous
1
2009
150
0.020
Why?
Lymphocytes
1
1990
153
0.020
Why?
Isoquinolines
1
2008
24
0.020
Why?
Cell Death
1
2009
177
0.020
Why?
Serine
1
2008
36
0.020
Why?
Tyrphostins
1
2008
9
0.020
Why?
Janus Kinases
1
2008
7
0.020
Why?
Physical Exertion
1
1988
46
0.020
Why?
Selection Bias
1
2008
15
0.020
Why?
Electrophoretic Mobility Shift Assay
1
2008
74
0.020
Why?
Pulse
1
1988
13
0.020
Why?
Pennsylvania
3
1993
34
0.020
Why?
Ischemic Preconditioning, Myocardial
1
2007
2
0.020
Why?
Enzyme Activation
1
2008
270
0.020
Why?
Organ Culture Techniques
1
2007
45
0.020
Why?
Creatine Kinase, BB Form
1
2007
1
0.020
Why?
Receptors, Purinergic P1
1
2007
7
0.020
Why?
Bayes Theorem
1
1988
121
0.020
Why?
Survival
1
2007
12
0.020
Why?
Theophylline
1
2007
17
0.020
Why?
Immunologic Factors
1
2008
117
0.020
Why?
Pyridazines
1
1987
10
0.020
Why?
5'-Nucleotidase
1
2007
12
0.020
Why?
Nitriles
1
2007
53
0.020
Why?
Pain
2
1982
362
0.020
Why?
Blood Coagulation
1
2007
64
0.020
Why?
Bundle-Branch Block
1
1987
18
0.020
Why?
Models, Chemical
1
2007
66
0.020
Why?
Premedication
1
2007
18
0.020
Why?
Evaluation Studies as Topic
3
1992
105
0.020
Why?
Butadienes
1
2007
49
0.020
Why?
Drug Combinations
1
2007
132
0.020
Why?
Depression, Chemical
1
1986
13
0.020
Why?
Coenzymes
1
2006
3
0.020
Why?
Stimulation, Chemical
1
1986
27
0.020
Why?
Vasoactive Intestinal Peptide
1
1986
20
0.020
Why?
Amrinone
1
1986
1
0.020
Why?
Heart Function Tests
1
1986
12
0.020
Why?
Oncogene Protein v-akt
1
2006
11
0.020
Why?
Fluid Therapy
1
2007
78
0.020
Why?
Receptors, Vasopressin
1
2006
23
0.020
Why?
Phosphoric Monoester Hydrolases
1
2006
23
0.020
Why?
Educational Measurement
1
2008
196
0.020
Why?
Alanine
1
2006
44
0.020
Why?
Amidines
1
2006
6
0.020
Why?
Lactates
1
1986
31
0.020
Why?
Benzylamines
1
2006
14
0.020
Why?
Protein Kinase Inhibitors
1
2008
227
0.020
Why?
Sulfones
1
2006
25
0.020
Why?
PTEN Phosphohydrolase
1
2006
55
0.020
Why?
Long-Term Care
1
1986
51
0.020
Why?
Research Design
1
2008
359
0.020
Why?
Models, Animal
1
2006
234
0.020
Why?
Magnetic Resonance Angiography
1
2006
67
0.020
Why?
Heart Conduction System
1
2005
24
0.020
Why?
Nitric Oxide
1
2007
249
0.020
Why?
Osmotic Pressure
1
1985
12
0.010
Why?
Half-Life
1
1985
88
0.010
Why?
Safety
1
2005
79
0.010
Why?
Osmolar Concentration
1
1985
62
0.010
Why?
Diabetes Mellitus
1
1989
316
0.010
Why?
Enzyme Inhibitors
1
2007
372
0.010
Why?
Aortography
1
2004
32
0.010
Why?
Glyburide
1
2004
5
0.010
Why?
Anastomosis, Surgical
1
2004
68
0.010
Why?
Scleroderma, Systemic
1
1984
6
0.010
Why?
Ventricular Fibrillation
1
2004
16
0.010
Why?
Anesthesia, Obstetrical
1
2004
39
0.010
Why?
Verapamil
1
1984
20
0.010
Why?
Models, Biological
1
2007
735
0.010
Why?
Vascular Surgical Procedures
1
2006
166
0.010
Why?
Statistics as Topic
1
2004
87
0.010
Why?
Patient Discharge
1
2006
330
0.010
Why?
Transcription Factors
1
2007
566
0.010
Why?
NG-Nitroarginine Methyl Ester
1
2003
12
0.010
Why?
Cesarean Section
1
2004
184
0.010
Why?
Pulmonary Artery
1
1984
150
0.010
Why?
Swine
1
2004
428
0.010
Why?
Endpoint Determination
1
2002
25
0.010
Why?
Thorax
1
1982
14
0.010
Why?
Anxiety Disorders
1
1982
130
0.010
Why?
Popliteal Artery
1
2000
28
0.010
Why?
Iliac Artery
1
2000
31
0.010
Why?
Hospitals, University
1
1999
75
0.010
Why?
Mortality
1
1999
105
0.010
Why?
Brain
1
2006
1323
0.010
Why?
Abdomen
1
1977
75
0.010
Why?
Dyspnea
1
1977
78
0.010
Why?
Pregnancy
1
2004
2680
0.010
Why?
Physical Examination
1
1977
99
0.010
Why?
Fatigue
1
1977
125
0.010
Why?
Physical Fitness
1
1997
57
0.010
Why?
Actuarial Analysis
1
1996
9
0.010
Why?
Walking
1
1997
104
0.010
Why?
Nitroprusside
1
1992
11
0.010
Why?
Neck
1
1993
97
0.010
Why?
Pilot Projects
1
1995
721
0.010
Why?
Transplantation, Heterotopic
1
1991
7
0.010
Why?
Regression Analysis
1
1991
401
0.010
Why?
Cyclosporine
1
1991
67
0.010
Why?
Cytotoxicity, Immunologic
1
1990
58
0.010
Why?
Histocompatibility Testing
1
1990
15
0.010
Why?
Transplantation, Heterologous
1
1989
79
0.010
Why?
Cell Division
1
1990
291
0.000
Why?
Length of Stay
1
1991
663
0.000
Why?
Bundle of His
1
1987
7
0.000
Why?
Atrial Flutter
1
1987
9
0.000
Why?
Phenotype
1
1990
789
0.000
Why?
Cobalt
1
1986
17
0.000
Why?
Histological Techniques
1
1986
9
0.000
Why?
Endomyocardial Fibrosis
1
1985
3
0.000
Why?
Doxorubicin
1
1986
241
0.000
Why?
Thallium
1
1984
6
0.000
Why?
Radioisotopes
1
1984
17
0.000
Why?
Heart Defects, Congenital
1
1990
619
0.000
Why?
Microcirculation
1
1984
64
0.000
Why?
Radionuclide Imaging
1
1984
107
0.000
Why?
Infant
1
1990
3733
0.000
Why?
Child, Preschool
1
1990
4076
0.000
Why?
Child
1
1990
7248
0.000
Why?
Uretsky's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description